Myriad Genetics Inc
MYGN- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000899923
No open-market purchases or sales by Myriad Genetics Inc insiders were filed in the last 90 days; 196 institutions reported holding it in 13F filings for Q2 2026, worth $507.8M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Myriad Genetics Inc changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 205 | 5 | 199 | −1 |
| Shares | 78.9M | 298.9K | 79.9M | +1.31M (+1.7%) |
| Value | $1.99B | $7.53M | $1.46B | −$524.5M (−26.5%) |
5 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (22)
Institutions that held Myriad Genetics Inc at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Connectus Wealth, LLC | 84,754 | $1.54M | 0.04% |
| Landscape Capital Management, L.L.C. | 57,293 | $1.04M | 0.14% |
| Caxton Associates LP | 29,319 | $533.0K | 0.07% |
| Ergoteles LLC | 28,637 | $520.0K | 0.02% |
| ETF Managers Group, LLC | 21,976 | $405.0K | 0.01% |
| Duality Advisers, LP | 21,188 | $385.0K | 0.04% |
| New York Life Investment Management LLC | 18,506 | $336.0K | 0.00% |
| Qube Research & Technologies Ltd | 18,025 | $328.0K | 0.00% |
| Gyon Technologies Capital Management, LP | 12,610 | $229.0K | 0.06% |
| E Fund Management Co., Ltd. | 12,481 | $227.0K | 0.02% |
| Walleye Trading LLC | 12,446 | $226.0K | 0.01% |
| KBC Group NV | 6,983 | $127.0K | 0.00% |
| Ronald Blue Trust, Inc. | 3,664 | $92.0K | 0.00% |
| First Horizon Advisors, Inc. | 3,190 | $57.0K | 0.00% |
| State of Wyoming | 804 | $15.0K | 0.01% |
| Venture Visionary Partners LLC | 500 | $9.09K | 0.00% |
| Investors Asset Management of Georgia Inc | 202 | $4.00K | 0.00% |
| Spire Wealth Management | 190 | $3.00K | 0.00% |
| Sound Income Strategies, LLC | 122 | $2.00K | 0.00% |
| Whittier Trust Co | 63 | $1.00K | 0.00% |
| Accel Wealth Management | 35 | $1.00K | 0.00% |
| Trust Co of Vermont | 2 | $0 | 0.00% |
Sold out (23)
Institutions that held Myriad Genetics Inc at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Millennium Management LLC | 344,987 | $8.69M |
| Marshall Wace, LLP | 91,025 | $2.29M |
| Pinz Capital Management, LP | 81,802 | $2.06M |
| Citadel Advisors LLC | 43,022 | $1.08M |
| HRT Financial LP | 41,813 | $1.05M |
| Jane Street Group, LLC | 33,814 | $852.0K |
| Brookfield Asset Management Inc. | 27,627 | $696.0K |
| Hillsdale Investment Management Inc. | 27,000 | $680.0K |
| Harvest Investment Services, LLC | 23,618 | $595.0K |
| Walleye Capital LLC | 15,852 | $399.0K |
| Caption Management, LLC | 15,000 | $378.0K |
| AlphaCrest Capital Management LLC | 14,792 | $373.0K |
| Alberta Investment Management Corp | 14,515 | $366.0K |
| Dynamic Technology Lab Private Ltd | 12,040 | $303.0K |
| Profund Advisors LLC | 8,761 | $221.0K |
| Dark Forest Capital Management LP | 309 | $8.00K |
| Prospera Financial Services Inc | 200 | $5.00K |
| Northwestern Mutual Wealth Management Co | 150 | $4.00K |
| Country Trust Bank | 151 | $4.00K |
| De Burlo Group Inc | 100 | $2.52K |
| Tarbox Family Office, Inc. | 87 | $2.00K |
| Allworth Financial LP | 9 | $0 |
| Cordant, Inc. | 5 | $0 |
Not filed for Q2 2022 yet (5)
Institutions that held Myriad Genetics Inc at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Parametric Portfolio Associates LLC | 227,160 | $5.72M |
| Amalgamated Financial Corp. | 35,745 | $901.0K |
| Teachers Retirement System of the State of Kentucky | 20,188 | $509.0K |
| IndexIQ Advisors LLC | 15,792 | $398.0K |
| SJS Investment Consulting Inc. | 1 | $0 |